News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Emily Drake: I finally joined Bluesky
Emily Drake/LinkedIn
Jan 20, 2025, 14:04

Emily Drake: I finally joined Bluesky

Emily Drake, Postdoctoral Researcher at McGill University, shared a post on LinkedIn:

“I did it. I finally joined Bluesky.

Please follow me. I only have 1 follower.

If you would like to follow those who work/advocate in adolescent and young adult oncology, please check out the starter pack I created!”

More posts featuring Emily Drake.

Bluesky cancer Emily Drake OncoDaily Oncology
Special Coverage
Blog
Jan 20, 2025, 14:04
Emily Drake: I finally joined Bluesky
Insight
Jan 20, 2025, 14:03
Richard Sullivan: Radiotherapy is the core modality in cancer care with proven ROI
Blog
Jan 20, 2025, 13:56
Kristina Jankovic: FDA approved datopotamab, deruxtecan-dlnk for unresectable, metastatic, HR+ HER2- breast cancer
Blog
Jan 20, 2025, 13:56
Luis Felipe Tapias: It has been 4 years since I started as a Thoracic Surgeon at Mayo Clinic
Opinion
Jan 20, 2025, 13:56
Amol Akhade: Do oncologists from LMICs and HICs treat and read about only certain solid tumors or all of them?
Blog
Jan 20, 2025, 13:55
Mayo Clinic Transplant completed over 2,000 solid organ transplants in 2024
Blog
Jan 20, 2025, 13:55
Paolo Tarantino: 10 facts to know on Dato-DXd
Blog
Jan 20, 2025, 13:55
Sarah Sammons: US women have a cancer problem that is getting worse
Blog
Jan 20, 2025, 13:55
"Light Through Darkness: Miracles Along My Cancer Journey" - Harriet Cabelly
Science
Jan 20, 2025, 13:55
Emre Yekedüz: New findings in high-risk NMIBC after BCG failure
Science
Jan 20, 2025, 13:55
Elisabetta Bonzano: Tumor-infiltrating lymphocytes in HER2-positive breast cancer: potential impact and challenges
Blog
Jan 20, 2025, 13:55
Jame Abraham: Looking for a Director of Transplant and Cellular Therapy Program at Cleveland Clinic